In this issue of The Lancet Diabetes & Endocrinology, Michelle M Chen and colleagues1 report their findings on trends in the incidence of thyroid cancer in the USA from 1975 to 2019. The authors show ...

The hypothalamic–pituitary–thyroid axis plays a crucial role in the pathogenesis, diagnosis, risk stratification, effectiveness of radioiodine therapy, and treatment response evaluation in epithelial ...

Targeted therapy for thyroid cancer with BRAF and RET inhibitors has progressed to Phase II clinical trials with first results on the therapeutic response pending.

Here, we report an unusual case of dermatomyositis that developed in a patient after the resection of thyroid cancer and breast cancer. The intercorrelation between dermatomyositis and neoplastic ...

Therefore, what are the realistic expectations for the state of thyroid cancer therapeutics in the coming years? Vandetanib is the only FDA-approved therapy currently available for the treatment ...

That doesn't mean I will talk poorly of Rahul Dravid. I like Rahul Dravid too, but I liked Sachin very much. And I consider Anil bhai (Anil Kumble) as a role model. I looked up to Harbhajan Singh ...

Recent observational studies have inconsistently reported associations of GLP-1 use with both medullary thyroid cancer and differentiated thyroid cancer, but these studies have been subject to bias.

Children diagnosed with cancer may be more likely to pass away if they are obese, an unsettling study has found. Obesity can increase the risk of some cancers, including breast, endometrial ...

PDGFRA expression boosts thyroid cancer cell proliferation and metastasis. Radiorefractory thyroid cancer is poorly differentiated, very aggressive, and resistant to radioiodine therapy. Thus, novel ...